Pregled bibliografske jedinice broj: 21096
Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by a coumarin derivative and by 4,4'-bipyridine
Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by a coumarin derivative and by 4,4'-bipyridine // Third International Meeting on Esterases Reacting with Organophosphorus Compounds, Dubrovnik, Programme and Abstracts / Reiner, Elsa (ur.).
Zagreb: Institut za medicinska istraživanja, 1998. (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 21096 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by a coumarin derivative and by 4,4'-bipyridine
Autori
Simeon-Rudolf, Vera ; Kovarik, Zrinka ; Radić, Zoran ; Reiner, Elsa
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Third International Meeting on Esterases Reacting with Organophosphorus Compounds, Dubrovnik, Programme and Abstracts
/ Reiner, Elsa - Zagreb : Institut za medicinska istraživanja, 1998
Skup
Third International Meeting on Esterases Reacting with Organophosphorus Compounds
Mjesto i datum
Dubrovnik, Hrvatska, 15.04.1998. - 18.04.1998
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
acetylcholinesterase; butyrylcholinesterase; 4;4'-bipyridine; coumarin derivative; reversible inhibition; molecular modelling
Sažetak
It was shown earlier that the coumarin derivative 3-chloro-7-hydroxy-4-methylcoumarin (CHMC) is an allosteric inhibitor of acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (BChE; 3.1.1.8) while 4,4'-bipyridine (4,4'-BP) binds to both the catalytic and allosteric site of the enzyme. Binding of the CHMC and 4,4'-BP to recombinant mouse w.t. AChE and BChE, to peripheral site-directed AChE mutants and to human serum BChE variants has now been studied. The enzyme activity was measured with acetylthiocholine as substrate. Enzyme/inhibitor dissociation constants for the catalytic and peripheral sites were evaluated from the apparent dissociation constants as a function of the substrate concentration (0.1 -10 mM). The competition between substrate and CHMC displayed two binding sites on AChE mutants Y72N, Y124Q, W286A and W286R, and the atypical and fluoride-resistant BChE variants. The dissociation constants for the peripheral site (from 0.06 to 0.1 mM) were on average two times higher than for the catalytic site (0.02 - 0.06 mM). CHMC displayed binding only to the catalytic site (Ka = 0.1 mM) of Y72N/Y124Q/W286A mutant and only to the peripheral site of AChE w.t. and usual BChE . 4,4'-BP bound to both sites of the AChE mutant Y72N/Y124Q/W286A, AChE w.t. and BChE w.t.. The two compounds had the lowest affinity for the Y72N/Y124Q/W286A mutant and displayed the most pronounced competition with acetylthiocholine over the studied substrate concentration range. However, the Michaelis constant of the mutant was similar to those of the other enzymes. The enhancement of competition might therefore be attributed, in part, to the differential effect of mutations on the binding of the substrate and the compounds CHMC or 4,4'-BP.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
00220104
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb